Cancer remains the leading cause of death around the world. In cancer treatment, over 50%
of cancer patients receive radiotherapy alone or in multimodal combinations with other …

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized
by excessive deposition of fibrotic connective tissue in the lungs. Emerging evidence …

Our previous study revealed that PI3K/AKT/mTOR signaling was associated with SCLC
radioresistance. SBC2 cells were used as primary radioresistance models, while H446 cells …

Radiotherapy is a prevalent treatment modality for thoracic tumors; however, it can lead to
radiation-induced lung injury (RILI), which currently lacks effective interventions. ACT001, a …

The NLRP3 inflammasome transforms a wide variety of infectious and non-infectious danger
signals that activate pro-inflammatory caspases, which promote the secretion of IL-1β and IL …

Pyroptotic cell death, an inflammatory form of programmed cell death (PCD), is emerging as
a potential therapeutic opportunity for radiotherapy (RT). RT is commonly used for cancer …

Radiation-induced pulmonary fibrosis (RIPF) represents a serious complication observed in
individuals undergoing thoracic radiation therapy. Currently, effective interventions for RIPF …

Radiation-induced lung injury is a common complication associated with radiotherapy. It is
characterized by early-stage radiation pneumonia and subsequent radiation pulmonary …

Radiation-induced lung fibrosis (RILF) is a common complication of radiotherapy in lung
cancer. However, to date no effective treatment has been developed for this condition …

Background: Radiation exposure has been linked to the development of brain damage and
cognitive impairment, but the protective effect and mechanism of Lycium barbarum pills …